Daptomycin Injection, Powder, Lyophilized, For Suspension
Product Images NDC 70436-033

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70436-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical structure diagram of daptomycin showing its complex molecular arrangement with various amino acid residues and functional groups. The diagram features standard chemical bonds and elements including carbon, oxygen, nitrogen, and hydrogen atoms.*

FDA Label Image

Vial-10000007001 (Image 02)

Label for daptomycin injection 500 mg per vial, lyophilized powder for intravenous use. The label indicates the need for reconstitution with 10 mL of 0.9% sodium chloride injection. It includes storage instructions to refrigerate at 2° to 8°C (36° to 46°F). The labeler is Slate Run Pharmaceuticals, LLC, with manufacturing by Hainan Poly Pharm Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.